Erlotinib HCl

CAS 183319-69-9

About the API

Technology High Potent
Therapeutic category Oncology
Available formulations Oral Solid
Regulations Canada DMF Flag Canada DMF EU DMF Flag EU DMF Korea DMF Flag Korea DMF US DMF Flag US DMF